Us Bancorp \De\ Genmab A/S Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Genmab A/S stock. As of the latest transaction made, Us Bancorp \De\ holds 171,669 shares of GMAB stock, worth $3.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

171,669

Previous 147,946 16.03%

Holding current value

$3.51 Million

Previous $3.72 Million 12.59%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$23.84 - $28.48 $565,556 - $675,631	23,723 Added 16.03%	171,669 $4.19 Million
Q2 2024 Aug 06, 2024	SELL	$25.13 - $30.27 $43,625 - $52,548	-1,736 Reduced 1.16%	147,946 $3.72 Million
Q1 2024 May 07, 2024	SELL	$26.43 - $32.77 $248,336 - $307,906	-9,396 Reduced 5.91%	149,682 $4.48 Million
Q4 2023 Feb 09, 2024	SELL	$27.94 - $35.44 $632,896 - $802,786	-22,652 Reduced 12.46%	159,078 $5.07 Million
Q3 2023 Nov 03, 2023	BUY	$35.27 - $42.24 $2.86 Million - $3.43 Million	81,213 Added 80.8%	181,730 $6.41 Million
Q2 2023 Aug 09, 2023	BUY	$37.4 - $42.94 $146,383 - $168,067	3,914 Added 4.05%	100,517 $3.82 Million
Q1 2023 May 09, 2023	SELL	$34.88 - $43.22 $53,087 - $65,780	-1,522 Reduced 1.55%	96,603 $3.65 Million
Q4 2022 Feb 13, 2023	BUY	$33.8 - $47.06 $189,753 - $264,194	5,614 Added 6.07%	98,125 $4.16 Million
Q3 2022 Oct 27, 2022	BUY	$31.52 - $373.61 $1.06 Million - $12.5 Million	33,531 Added 56.85%	92,511 $2.97 Million
Q2 2022 Aug 01, 2022	SELL	$26.83 - $38.57 $529,382 - $761,024	-19,731 Reduced 25.07%	58,980 $1.92 Million
Q1 2022 May 11, 2022	BUY	$30.95 - $39.68 $83,162 - $106,620	2,687 Added 3.53%	78,711 $2.85 Million
Q4 2021 Feb 11, 2022	BUY	$35.87 - $47.12 $53,589 - $70,397	1,494 Added 2.0%	76,024 $3.01 Million
Q3 2021 Nov 10, 2021	BUY	$41.55 - $48.72 $536,368 - $628,926	12,909 Added 20.95%	74,530 $3.26 Million
Q2 2021 Aug 05, 2021	BUY	$32.88 - $44.57 $1.18 Million - $1.6 Million	35,846 Added 139.07%	61,621 $2.52 Million
Q1 2021 Apr 28, 2021	BUY	$30.92 - $44.4 $86,112 - $123,654	2,785 Added 12.11%	25,775 $846,000
Q4 2020 Feb 04, 2021	SELL	$33.66 - $40.76 $998,389 - $1.21 Million	-29,661 Reduced 56.34%	22,990 $936,000
Q3 2020 Nov 10, 2020	BUY	$33.07 - $38.68 $1.51 Million - $1.77 Million	45,769 Added 665.05%	52,651 $1.93 Million
Q2 2020 Aug 07, 2020	BUY	$20.05 - $33.89 $2,305 - $3,897	115 Added 1.7%	6,882 $233,000
Q1 2020 May 13, 2020	SELL	$17.15 - $25.22 $2,949 - $4,337	-172 Reduced 2.48%	6,767 $143,000
Q4 2019 Feb 04, 2020	BUY	$18.88 - $24.14 $32,605 - $41,689	1,727 Added 33.14%	6,939 $155,000
Q3 2019 Nov 08, 2019	BUY	$18.0 - $21.38 $93,816 - $111,432	5,212 New	5,212 $105,000

Others Institutions Holding GMAB

# of Institutions

238

Shares Held

52.6M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.5B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account